🔴 CALC pulls back 8.2% after recent private placement financing and FDA update

CALC is trading 8.2% down at $0.57 in pre-market. The pullback follows recent sharp volatility and a 4.8% gain on June 25, 2026, which occurred after: - CalciMedica (CALC) announced a private placement of up to $49 million to advance its pulmonary hypertension program on June 24, 2026. - The FDA raised no objections to amendments in the company's Phase 2 KOURAGE study for Auxora, allowing continued patient dosing, also announced on June 24, 2026.